Gilead Sciences, Inc (GILD) TD Cowen Annual Health Care Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference
Analysis
S&P 500 Gains as Risk-On Rotation Sends Energy Up 1.84%, Utilities Down 1.68%
S&P 500 gains 0.52% as energy surges 1.84% and tech adds 1.34%, while utilities tumble 1.68% in risk-on rotation.
Gilead Sciences, Inc (GILD) Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Sec Form 8K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 8K
ADVERTISEMENT
AlphaGraphs
Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues
Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, has reported a decline in adjusted earnings for the fourth quarter...
Gilead Sciences, Inc (GILD) Dividend Update
Gilead Sciences, Inc (NASDAQ: GILD) Q1 2026 Dividend Update
Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call
Gilead Sciences, Inc (NASDAQ: GILD) Q4 2025 Earnings Conference
Gilead Sciences, Inc (GILD) FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
ADVERTISEMENT
Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…
Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…